Position in SANA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,326,076
+$4,281,994 QoQ
Shares Held
4,677,959
+11.9% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. SANA ranks #151 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,326,076 | 4,677,959 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,044,082 | 4,181,973 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,760,821 | 4,118,138 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,153,538 | 3,423,532 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $8,953,829 | 3,279,791 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,502,449 | 3,275,268 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,204,721 | 3,193,081 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,172,556 | 3,166,480 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,781,720 | 2,890,425 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $24,165,180 | 2,416,518 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,195,650 | 2,253,836 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,924,165 | 2,047,588 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,815,878 | 1,982,530 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,823,755 | 1,780,965 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,143,037 | 1,808,364 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,191,006 | 1,698,501 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,617,357 | 1,651,222 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,610,632 | 1,526,711 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,981,352 | 1,549,183 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $34,717,552 | 1,541,632 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,817,875 | 550,248 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,804,266 | 412,437 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||